SHARE Receives Grant to Support Patients with Metastatic Disease

SHARE is one of 23 organizations nationwide to receive funding through the Avon-Pfizer Metastatic Breast Cancer Grants Program: Identify-Amplify-Unify. SHARE will receive $25K to continue our peer and professionally led support and informational services for people affected by metastatic breast cancer. We currently offer nine support groups per month for people with metastatic disease, as well as telephone support through our helpline, and educational webinars and programs.

The goal of the Avon-Pfizer program is to support and educate more than 5,000 metastatic breast cancer patients, their caregivers, and their communities, and to increase public understanding of the disease.

"To date, the majority of public attention on and funding for breast cancer has centered on early-stage disease – such as screening strategies and survivorship – not on late-stage diagnosis. As a result, the Avon-Pfizer Metastatic Grants Program was established to address the gaps in support available to women and men living with metastatic disease, and to create new services for metastatic patients so they do not have to face this disease alone," said Marc Hurlbert, executive director of the Avon Foundation for Women Breast Cancer Crusade. "Our hope is that one day, all patients can access the unique care and support services they need, regardless of their ability to pay."

Metastatic breast cancer is the most advanced stage of breast cancer and occurs when cancer spreads beyond the breast to other parts of the body, including the bones, lungs, liver and brain. Nearly three in 10 women who have had early breast cancer will eventually develop metastatic disease. There are no cures currently available, and continuous treatment is needed to control the spread of the disease and its symptoms.